retatrutide nonalcoholic fatty liver disease trial Retatrutide: A Promising Breakthrough for Retatrutide the wonder drug: What's

Research about this GLP-1 side effect is still limited, but that doesnt mean its all in peoples heads

Risk of Hypoglycemia: While GLP-1 medications are not typically associated with an increased risk of hypoglycemia when used as monotherapy, they may potentiate the effects of other antidiabetic medications that can cause hypoglycemia, such as sulfonylureas or insulin

The Rise of GLP1 Drugs for Weight Loss GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a revolutionary class of injectable or oral medications originally developed for type 2 diabetes, but now widely used for chronic weight management

Int J Mol Sci (2017) 18(7):1583

Avoid greasy, spicy, very rich, or high-sugar foods for now

doi: 10.1152/ajpregu.00755.2010